Definitive Contract 75A50123C00037
Award Date
7/31/23
Potential Completion Date
7/29/33
Potential Value
$763M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Gaithersburg, MD 20879, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,403,362,669.10 cost-plus-fixed-fee contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Product Development Gaithersburg Inc., a for-profit limited liability company manufacturing medical countermeasures and pharmaceuticals. The contract, which has a period of performance through September 29, 2026, is for the development of filovirus treatments. Emergent has received over $1.3...
This is a $19,763,563.00 cost-plus-fixed-fee delivery order contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract was awarded to Emergent Manufacturing Operations Baltimore LLC, a for-profit limited liability company and manufacturer of goods registered in the System for Award Management (SAM). The contract is part of the Centers for Innovation in Advanced...
This is a $99,941,719.80 definitive, firm fixed-price contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Emergent Biodefense Operations Lansing LLC, doing business as Emergent Biodefense, on March 16, 2017. The contract has an ultimate completion date of March 15, 2019 and is not set aside. Emergent Biodefense is a for-profit manufacturer of medical countermeasures and biopharmaceuticals, specializing in vaccines and therapeutics for public health...
This is a $38,243,034.02 cost-plus-fixed-fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Mapp Biopharmaceutical, Inc. for the development of medical countermeasures through planned clinical trials and outbreak preparedness. The contract is not set aside. The original solicitation was a Broad Agency Announcement from BARDA seeking proposals for advanced research and development of medical countermeasures against chemical, biological,...
This is a $856,704,795.58 definitive cost-plus-fixed-fee contract awarded by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to Mapp Biopharmaceutical, Inc., a biotechnology company specializing in infectious disease treatments. The contract is for the procurement of therapeutics to address Ebola, Sudan, and Marburg viruses. There is no set-aside designation for this contract, which has an ultimate completion date of...
This is a firm fixed price delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency under the Department of Health and Human Services (HHS), to Emergent Manufacturing Operations Baltimore LLC, a for-profit manufacturer of medical countermeasures. The $196,434,000 award is for the provision of anthrax antitoxins to treat inhalational anthrax, under the agency's medical countermeasures development and procurement program. The...
This is a $23,109,340.68 cost-plus-fixed-fee delivery order awarded to Emergent Manufacturing Operations Baltimore LLC, a for-profit limited liability company manufacturer, by the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services. The contract is for the development of a plasma-derived polyclonal antibody-based COVID-19 therapeutic, under the Centers for Innovation in Advanced Development and Manufacturing program. No...
The U.S. Department of Health and Human Services (HHS), through the Office of the Assistant Secretary for Preparedness and Response (ASPR), awarded a $630,384,987.00 firm-fixed-price definitive contract to Emergent BioDefense Operations Lansing LLC for the advanced research and development of a smallpox antiviral drug. This award is not associated with a set-aside contract and is part of ASPR's broader efforts to procure and stockpile alternative smallpox antivirals. The original procurement was...
This is a definitive contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Biodefense Operations Lansing LLC, a for-profit manufacturer of medical countermeasures. The $1,174,464,339.10 firm fixed-price contract is for the production of BioThrax, the only FDA-licensed vaccine for the prevention of anthrax disease, which is a critical component of the U.S. government's strategic national stockpile. The...
This is a $20,000,000.00 firm fixed price delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Emergent Manufacturing Operations Baltimore LLC, a for-profit manufacturing company. The award is to expand the public-private partnership with Emergent and reserve the capacities and capabilities at Emergent's Bayview Center for Innovation in Advanced Development and...